Reimbursement Workshop

  • Wednesday, June 30th at 9:50-10:35 & 1:30-2:15
    Avoid costly and time-consuming errors.

    This workshop will cover the importance of including reimbursement early in the strategic planning to avoid costly and time-consuming errors. With healthcare reform underway, it will be imperative to be more aggressive in developing robust reimbursement plans and consider evidence development much earlier in the planning cycle.

    During this workshop, you will learn how:
    •Healthcare reform may impact your company.

    •Investigating the potential reimbursement landscape early in product development can favorably impact product design, investor acceptance and commercialization.

    •To avoid the most common mistakes companies make in applying for new codes and payment rates.

    •Evidence-based medicine, comparative effectiveness and value-based purchasing affect medical technology. You will also learn how a manufacturer can obtain reimbursement for their products during clinical trials.

    •Your company valuation can improve with a pricing strategy that connects the clinical or economic value of the technology.

    •To understand the financial motivations of physicians, hospitals and insurers and how this economic value story should influence every aspect of product development, from product design to valuation to commercialization.

    Patty Telgener, Director of Pricing and Reimbursement, Gershon Capital & Cie
    Patty has been involved in research and due diligence activities for numerous new technologies. These market research activities included clinical research, competitive analysis (devices and pharmaceutical interventions) and economic analysis. Patty has also leveraged this research to help payer and provider customers understand the clinical and economic impact of new technologies. Patty has a strong understanding of what clinical and economic data is necessary to bring a product to market and secure positive coverage and payment determinations.

  • Conference Info:

     

    Date: June 26-27, 2013
    Location: The Metropolitan Club, New York City


    Audience: Institutional investors, high net worth individual investors, family offices, business development executives throughout the US and Europe building and financing high growth medical technology, health care and life science companies.

    View the Schedule!

    View the Agenda!